FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 12.765
NA - Nord America 4.099
AS - Asia 2.588
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 61
OC - Oceania 24
Totale 19.893
Nazione #
IT - Italia 9.821
US - Stati Uniti d'America 3.994
RU - Federazione Russa 1.111
SG - Singapore 781
CN - Cina 699
NL - Olanda 550
HK - Hong Kong 300
KR - Corea 225
IE - Irlanda 221
BR - Brasile 204
VN - Vietnam 201
SE - Svezia 169
FR - Francia 160
DE - Germania 140
CH - Svizzera 129
GB - Regno Unito 107
PL - Polonia 97
IN - India 90
FI - Finlandia 88
CA - Canada 56
TR - Turchia 49
JO - Giordania 46
ES - Italia 34
BD - Bangladesh 33
AR - Argentina 27
ID - Indonesia 26
MX - Messico 25
AU - Australia 24
JP - Giappone 24
BE - Belgio 17
IQ - Iraq 15
UA - Ucraina 15
AT - Austria 13
DK - Danimarca 12
EC - Ecuador 12
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 11
SA - Arabia Saudita 11
RO - Romania 10
ZA - Sudafrica 10
LT - Lituania 9
RS - Serbia 9
MA - Marocco 8
CZ - Repubblica Ceca 7
EG - Egitto 7
IR - Iran 7
NG - Nigeria 7
CI - Costa d'Avorio 6
NO - Norvegia 6
TW - Taiwan 6
BG - Bulgaria 5
BJ - Benin 5
CL - Cile 5
CO - Colombia 5
GR - Grecia 5
HN - Honduras 5
MY - Malesia 5
UZ - Uzbekistan 5
JM - Giamaica 4
MD - Moldavia 4
MT - Malta 4
PT - Portogallo 4
TN - Tunisia 4
DZ - Algeria 3
GH - Ghana 3
IL - Israele 3
LV - Lettonia 3
MM - Myanmar 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SI - Slovenia 3
SM - San Marino 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MG - Madagascar 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PY - Paraguay 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
Totale 19.790
Città #
Milan 1.082
Santa Clara 940
Rome 860
Ashburn 678
Singapore 592
Florence 291
Hong Kong 259
Turin 235
Seoul 225
Bologna 215
Dublin 212
Hefei 210
San Jose 189
Naples 183
Chandler 136
Verona 129
Fairfield 118
Beijing 112
Genoa 108
Bari 105
Palermo 87
Dallas 81
Los Angeles 80
Ho Chi Minh City 72
Moscow 71
Council Bluffs 69
Padova 69
Modena 66
Warsaw 64
Munich 63
Brescia 60
New York 59
Lawrence 58
Venice 58
Altamura 57
Catania 50
Rimini 49
Lauterbourg 48
Hanoi 45
Houston 45
Monza 43
Livorno 42
Padua 42
Woodbridge 41
Buffalo 40
Cambridge 40
Helsinki 40
Perugia 40
Seattle 40
Wilmington 40
Boston 37
Mumbai 37
Parma 37
Princeton 35
Cagliari 32
Turku 32
Zurich 32
Trieste 31
Vicenza 31
The Dalles 30
Trento 30
Bern 29
Kent 29
Pescara 29
Shanghai 29
São Paulo 29
Prato 28
Frankfurt am Main 27
London 27
Reggio Emilia 26
Bergamo 24
Jakarta 24
Tokyo 22
Hangzhou 21
Lucca 21
Orem 21
San Diego 21
Melbourne 20
Messina 19
Treviso 19
Bolzano 18
Taranto 18
Ancona 17
Ann Arbor 17
Pisa 17
Figino 16
Paris 16
Atlanta 15
Cesena 15
Adapazarı 14
Grottaglie 14
Montreal 14
Bengaluru 13
Boardman 13
Cologno Monzese 13
Imola 13
Lappeenranta 13
Toronto 13
Brooklyn 12
Hillsboro 12
Totale 9.660
Nome #
Ascolto di musica a 440 HZ versus musica a 432 HZ per la riduzione dell’ansia covid correlata negli infermieri del 118: un trial pilota randomizzato controllato in doppio cieco 10.565
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 372
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 290
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 230
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 219
Biometric refractive error after cataract and retina surgery: a systematic review and a benchmark proposal 212
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 208
LA TERAPIA ANTICOAGULANTE ORALE IN PAZIENTI DI ETÀ AVANZATA CON FIBRILLAZIONE ATRIALE È ANCORA POCO UTILIZZATA. UN’ANALISI DEL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 206
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 203
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 201
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 199
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 193
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 192
Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population 186
The Listening to music tuned to 440 Hz versus 432 Hz to reduce anxiety and stress in emergency nurses during the COVID-19 pandemic: a double-blind, randomized controlled pilot study 183
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 179
Correction to: Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (Journal of Nuclear Cardiology, (2022), 10.1007/s12350-022-02911-y) 173
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 172
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 170
Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy 169
P392Preliminary evaluation of stress myocardial blood flow pattern in patients with apical hypertrophic cardiomyopathy candidate to be enrolled in the CARAPACE study 168
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 168
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 167
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 167
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 167
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 165
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 165
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 164
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 164
Lower extremity performance predicts length of hospital stay in older candidates to elective cardiac surgery 163
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 160
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 159
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 158
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 157
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 157
From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy 156
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 156
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 155
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 152
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 152
EFFETTI DELLA TERAPIA PRE-RICOVERO CON ANTAGONISTI DEL SISTEMA RENINA-ANGIOTENSINA IN PAZIENTI DI ETÀ AVANZATA CON COVID-19. DAL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 151
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 150
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 145
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 143
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 142
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 142
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 141
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 141
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 135
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 134
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 134
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 131
The Importance of Sex Differences in Patients with Hypertrophic Cardiomyopathy – Tailoring Management and Future Perspectives 128
β-blockers: Their new life from hypertension to cancer and migraine 127
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 107
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 93
null 7
Totale 19.893
Categoria #
all - tutte 42.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 0 6 11 9 15 17 6 23 35 21 52 72
2022/2023898 56 180 51 39 61 152 124 59 99 7 36 34
2023/20241.603 28 52 72 29 62 92 47 147 53 226 359 436
2024/20258.948 1.019 691 614 1.090 1.280 798 556 647 594 527 585 547
2025/20266.725 576 780 644 634 714 287 678 448 296 477 476 715
2026/20271.054 450 604 0 0 0 0 0 0 0 0 0 0
Totale 19.893